Horizon 2020 Prize for the Better Use of Antibiotics awarded
On 6 February 2017, Carlos Moedas, Commissioner for Research, Science and Innovation, handed over a €1 million Horizon Prize for Better Use of Antibiotics, and Vytenis Andriukaitis, Commissioner for Health and Food Safety, delivered the EU Health Award for NGOs fighting Antimicrobial Resistance, at an award ceremony hosted by the University of Leuven in Belgium.
The €1 million Horizon Prize is for a finger prick test that can diagnose in less than ten minutes a bacterial infection and identify if a patient can be treated safely without antibiotics. The easy-to-use test is expected to be available for patients by 2018. It has been developed by Minicare HNL, a combined research effort of P&M Venge AB from Sweden and PHILIPS Electronics from the Netherlands.
The EU Health Award for NGOs fighting Antimicrobial Resistance recognises outstanding initiatives by NGOs to reduce the threat of antimicrobial resistance (AMR) to human health.
For the Better Use of Antibiotics Prize, two other finalists were in close competition, presenting innovative patient-focused technologies. They were:
- PulmoCheck, who are developing a device that reacts within 2-6 minutes to body fluids derived from a bacterial infection
- ImmunoPoc, for a finger prick test that can differentiate between bacterial and viral infections within fifteen minutes.
Horizon Prizes are 'challenge' prizes (also known as ‘inducement' prizes) offering a cash reward to whoever can most effectively meet a defined challenge. Horizon Prizes do not prescribe the methodology or any technical details, giving applicants total freedom to come up with the most promising and effective solution. The aim is to stimulate innovation and come up with solutions to problems that matter to European citizens.TOP